Stem Cell Therapy in Autoimmune Diseases

Biomarkers, represented by genetically determined traits or biologic changes predictive of disease onset or outcome, are increasingly employed by academic and industrial investigators. They can identify unusually susceptible populations or individuals, facilitate prognosis, Currently, autoimmune conditions are treated with immune suppressive agents such as steroids, methothrexate, cyclosporine, gold, and more recently infliximab (Remicade). 
 

  • Hematopoietic Stem Cell Therapy for Autoimmune Diseases
  • Development of Hematopoietic Stem Cell Lines for Transplantation
  • Gene Therapy and Stem Cell Approaches for the Treatment of Autoimmune Diseases

Stem Cell Therapy in Autoimmune Diseases Conference Speakers

Recommended Sessions

Related Journals

Are you interested in